Treatment of Graves' disease: The advantages of surgery

被引：54

作者：

Alsanea, O

Clark, OH

机构：

[1] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Med Ctr, Dept Surg, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2000年 / 29卷 / 02期

关键词：

D O I：

10.1016/S0889-8529(05)70134-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article reviews the current trends and methods used to treat Graves' disease. The modern history of the treatment of Graves' disease illustrates the history of modern surgery in Europe and the United States. Factors influencing the decision to choose between subtotal and total thyroidectomy are discussed with reference to recurrence and complications of each procedure. The management of Graves' disease in patients with eye disease or coexisting malignancy also is detailed.

引用

收藏

页码：321 / +

页数：18

相关论文

共 105 条

[1] HISTORICAL VIGNETTE - THE KNIFE THAT SAVES - MEMOIRS OF A LAHEY-CLINIC SURGEON [J].

ADAMS, HD .

SURGICAL NEUROLOGY, 1992, 38 (04) :318-319

[2] SURGERY FOR HYPERTHYROIDISM - HEMITHYROIDECTOMY PLUS CONTRALATERAL RESECTION OR BILATERAL RESECTION - A PROSPECTIVE RANDOMIZED STUDY OF POSTOPERATIVE COMPLICATIONS AND LONG-TERM RESULTS [J].

ANDAKER, L ;

JOHANSSON, K ;

SMEDS, S ;

LENNQUIST, S .

WORLD JOURNAL OF SURGERY, 1992, 16 (04) :765-769

[3] THYROID DISORDERS-A HALF CENTURY OF INNOVATION [J].

ASTWOOD, EB .

ANNALS OF INTERNAL MEDICINE, 1965, 63 (04) :553-+

[4] Genetic markers in diagnosis and prediction of relapse in Graves' disease [J].

Badenhoop, K ;

Donner, H ;

Braun, J ;

Siegmund, T ;

Rau, H ;

Usadel, KH .

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 :98-100

[5] ORBITAL COBALT IRRADIATION COMBINED WITH SYSTEMIC CORTICOSTEROIDS FOR GRAVES OPHTHALMOPATHY - COMPARISON WITH SYSTEMIC CORTICOSTEROIDS ALONE [J].

BARTALENA, L ;

MARCOCCI, C ;

CHIOVATO, L ;

LADDAGA, M ;

LEPRI, G ;

ANDREANI, D ;

CAVALLACCI, G ;

BASCHIERI, L ;

PINCHERA, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (06) :1139-1144

[6] USE OF CORTICOSTEROIDS TO PREVENT PROGRESSION OF GRAVES OPHTHALMOPATHY AFTER RADIOIODINE THERAPY FOR HYPERTHYROIDISM [J].

BARTALENA, L ;

MARCOCCI, C ;

BOGAZZI, F ;

PANICUCCI, M ;

LEPRI, A ;

PINCHERA, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1349-1352

[7] RADIOIODINE THERAPY FOR HYPERTHYROIDISM IN YOUNG-PATIENTS - PERCEPTION OF RISK AND USE [J].

BAXTER, MA ;

STEWART, PM ;

DAYKIN, J ;

SHEPPARD, MC ;

FRANKLYN, JA .

QUARTERLY JOURNAL OF MEDICINE, 1993, 86 (08) :495-499

[8] Radioiodine and thyroid disease: The beginning [J].

Becker, DV ;

Sawin, CT .

SEMINARS IN NUCLEAR MEDICINE, 1996, 26 (03) :155-164

[9] Early occurrence of a thyroid carcinoma in a patient who developed Graves' disease after treatment for Hodgkin's disease [J].

Belfiore, A ;

Pellegriti, G ;

Milone, G ;

Vigneri, G ;

Gangemi, P ;

Fiumara, A ;

Vigneri, R .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (11) :869-871

[10] Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study [J].

Benker, G ;

Reinwein, D ;

Kahaly, G ;

Tegler, L ;

Alexander, WD ;

Fassbinder, J ;

Hirche, H .

CLINICAL ENDOCRINOLOGY, 1998, 49 (04) :451-457

← 1 2 3 4 5 6 7 8 9 10 →